HOME >> BIOLOGY >> NEWS
Experts to share biotech future world

ROCKVILLE, Md. --A child born in 2010 should benefit from better health and disease diagnosis, improved foods, more efficient clean up of toxin spills, and a more "realistic" view of evolution, thanks to the current revolution in applying biotechnology to the flood of new gene sequencing data. Leading experts will discuss what's in store for the 2010 genomic generation at a special symposium, "Advancing the Frontiers of Biotechnology" at the University System of Maryland's Shady Grove Campus (directions below), 8:30 a.m., November 9.

The free symposium will be held in honor of the inauguration of Jennie Hunter-Cevera, Ph.D., as the second president of the University of Maryland Biotechnology Institute (UMBI) on November 10, also at USM, Shady Grove.

"It is indeed an honor for UMBI to host such a distinguished group of speakers (list below) in the heart of Maryland's "Genomic Junction" who will discuss the future of biotechnology," says Hunter-Cevera. She was most recently head of the Center for Environmental Biotechnology and director of the Department of Environmental Biology and Biochemistry for the Lawrence Berkeley National Laboratory, University of California.

At the inaugural symposium, experts will discuss likely changes for the post-2010 "genomics" generation, including:

  • Preventing Infections: Analysis of all the genes of both humans and human disease-causing microorganisms will give drug designers pinpoint accuracy to treat infectious diseases from influenza to AIDS on a patient-to-patient basis.
  • Monitoring Cancer Treatments: Tissue microarray technology, so far replacing microscope slide tests in 100 laboratories in the world, will help clinicians get 9,000 different analyses of 1,000 tissue samples at once for a rapid diagnosis of cancer type, progression, and patient risk factors.
  • Green Manufacturing: Computer analysis of microbial enzyme genes will help manufacturers, e.g. paper mills, to limit use of sulfur and other p
    '"/>


Contact: Steve Berberich
berberic@umbi.umd.edu
410-385-6315
University of Maryland Biotechnology Institute
2-Nov-2000


Page: 1 2 3

Related biology news :

1. Experts to lecture in US cities this spring about new human origins research
2. Experts to demonstrate latest, cost-cutting computer-based caregiving for older Americans
3. Experts deliver foot and mouth disease warning
4. Experts offer the skinny on search for healthy fat
5. Experts discuss recommendations of NY state task force on genetic testing
6. Expanded Global Change Experts Directory available
7. NASA Materials Conference Features Science Results, Experts on Technologies for Exploration
8. Experts meet to evaluate watershed restoration for salmon in Pacific rivers
9. Experts say independent scientific panels useful in advising judges in complex cases
10. Experts say diet and exercise play critical role in cancer prevention
11. Experts to study informed consent in national gene transfer research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
Cached News: